NMT1 and infection: Accordingly, the small molecule NMT inhibitor PCLX-001 has been shown to be safe and well tolerated in humans [28,29], supporting the interest in exploring the repurposing of NMT inhibitors to treat infections by human pathogenic mammarenaviruses.